Metosartan LN 50 Tablet ER
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Cilnidipine (10mg) + Metoprolol Succinate (47.5mg) + Telmisartan (40mg)
Overview Metosartan LN 50 Tablet ER
Atelmisartan/Hydrochlorothiazide 50mg extended-release tablets are prescribed for hypertension management when monotherapy proves insufficient. This combination medication lowers elevated blood pressure, thereby diminishing the risk of stroke and myocardial infarction. The tablets can be ingested with or without food, but consistent daily timing is recommended. Continue treatment as directed by your physician; discontinuation, even with symptom absence, may exacerbate your condition. Lifestyle modifications, including regular physical activity, weight management, and a balanced diet, complement this therapy. Adhere to your doctor's instructions. Potential side effects include nausea, altered taste perception, pharyngitis, lumbago, and edema. Elevating your legs can mitigate ankle swelling. Potassium-rich foods and supplements should be avoided. Regular monitoring of blood pressure, renal function, glycemia, and electrolytes may be necessary. Prior to initiating treatment, disclose any liver or kidney disease to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Inform your doctor about all concurrent medications, particularly those for hypertension or cardiac issues.
Primary Ingredients of Metosartan LN 50 Tablet ER
No text provided to rephrase.
Uses of Metosartan LN 50 Tablet ER
Elevated blood pressure
Major Benefits of Metosartan LN 50 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metosartan LN 50 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Metosartan LN 50 Tablet ER:
- Nausea
- Taste change
- Diarrhea
- Headache
- Dizziness
- Weakness
- Ankle swelling
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Edema (swelling)
- Slow heart rate
- Cold extremities
- Decreased blood pressure
- Throat infection
How to use Metosartan LN 50 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metosartan LN 50 Tablet ER whole; avoid crushing, chewing, or breaking it. Administer this medication with food.
How Metosartan LN 50 Tablet ER works:
Extended-release Metosartan LN 50 tablets contain a triple-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metosartan LN 50 Tablet ER and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Metosartan LN 50 Extended-Release tablets is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Metosartan LN 50 Tablet ER with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Extended-release Metosartan LN 50mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Metosartan LN 50 Tablet ER in individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Metosartan LN 50 Tablet ER cautiously, potentially requiring dosage modification. Physician consultation is advised. Metosartan LN 50 Tablet ER is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Metosartan LN 50 Tablet ER :
Should you forget to take a Metosartan LN 50 Tablet ER, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Metosartan LN 50 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |




